Clinical Trial Uncertainty: The success of clinical trials for its medical devices, particularly the INSPIRA ART, is critical for regulatory approval and commercialization. Delays, failures, or adverse results in these trials could significantly impact product development timelines and market viability.

Regulatory Approval Hurdles: Obtaining necessary regulatory approvals (e.g., FDA, CE Mark) for its products is a complex, lengthy, and uncertain process. Any failure to secure or maintain these approvals would prevent market entry or continued sales.

Intense Market Competition: The medical device market, particularly for respiratory support and oxygenation technologies, is highly competitive with established players and new entrants. Inspira Technologies may struggle to differentiate its products or gain significant market share against larger, more resourced competitors.